Company Registration No. NI709560 (Northern Ireland)
Antigenesis Biologics Ltd
Unaudited accounts
for the year ended 28 February 2026
Antigenesis Biologics Ltd
Unaudited accounts
Contents
Antigenesis Biologics Ltd
Company Information
for the year ended 28 February 2026
Directors
Mr Terence Hugh Brannigan
Dr Ciaran Patrick Anthony Doherty
Dr Hugh Patrick Morgan
Company Number
NI709560 (Northern Ireland)
Registered Office
78 Teconnaught Road
Crossgar
Downpatrick
County Down
BT30 9HH
Northern Ireland
Accountants
Nuvem 9 Ltd
The Mount Business Centre
Woodstock Link
Belfast
County Antrim
BT6 8DD
Antigenesis Biologics Ltd
Statement of financial position
as at 28 February 2026
Tangible assets
18,176
23,012
Cash at bank and in hand
179,262
31,350
Creditors: amounts falling due within one year
(126,459)
(9,255)
Net current assets
80,651
43,075
Called up share capital
10
10
Share premium
50,000
50,000
Profit and loss account
48,817
16,077
Shareholders' funds
98,827
66,087
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 September 2026 and were signed on its behalf by
Dr Hugh Patrick Morgan
Director
Company Registration No. NI709560
Antigenesis Biologics Ltd
Notes to the Accounts
for the year ended 28 February 2026
Antigenesis Biologics Ltd is a private company, limited by shares, registered in Northern Ireland, registration number NI709560. The registered office is 78 Teconnaught Road, Crossgar, Downpatrick, County Down, BT30 9HH, Northern Ireland.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
5 year straight line
Computer equipment
3 year straight line
4
Tangible fixed assets
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 March 2025
20,847
2,757
23,604
At 28 February 2026
20,847
3,112
23,959
At 1 March 2025
263
329
592
Charge for the year
4,169
1,022
5,191
At 28 February 2026
4,432
1,351
5,783
At 28 February 2026
16,415
1,761
18,176
At 28 February 2025
20,584
2,428
23,012
Antigenesis Biologics Ltd
Notes to the Accounts
for the year ended 28 February 2026
Amounts falling due within one year
Accrued income and prepayments
4,607
6,463
6
Creditors: amounts falling due within one year
2026
2025
Taxes and social security
1,094
1,039
Loans from directors
577
-
7
Average number of employees
During the year the average number of employees was 2 (2025: 2).